pCAGGS SARS-CoV-2 BA.1 Spike Citations (1)

Originally described in: SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses.
Chatterjee D, Tauzin A, Marchitto L, Gong SY, Boutin M, Bourassa C, Beaudoin-Bussieres G, Bo Y, Ding S, Laumaea A, Vezina D, Perreault J, Gokool L, Morrisseau C, Arlotto P, Fournier E, Guilbault A, Delisle B, Levade I, Goyette G, Gendron-Lepage G, Medjahed H, De Serres G, Tremblay C, Martel-Laferriere V, Kaufmann DE, Bazin R, Prevost J, Moreira S, Richard J, Cote M, Finzi A Cell Rep. 2022 Mar 1;38(9):110429. doi: 10.1016/j.celrep.2022.110429. Epub 2022 Feb 8. PubMed Journal

---

Articles Citing pCAGGS SARS-CoV-2 BA.1 Spike

Articles
Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin. Shi Y, Simpson S, Chen Y, Aull H, Benjamin J, Serra-Moreno R. PLoS Pathog. 2024 Jan 8;20(1):e1011912. doi: 10.1371/journal.ppat.1011912. eCollection 2024 Jan. PubMed

If you have published an article using this material, please email us at to have your article added to this page.